Efficacy of ALK inhibitors on NSCLC brain metastases: A systematic review and pooled analysis of 21 studiesFausto Petrelli(Azienda Ospedaliera Treviglio), Vanesa Gregorc(IRCCS Ospedale San Raffaele)PLoS ONEJuly 27, 201810.1371/journal.pone.0201425Cited by 52SaveCiteExport RISWatch citationsRelated PapersFluorouracil and dose-dense adjuvant chemotherapy in patients with early-stage breast cancer (GIM2): end-of-study results from a randomised, phase 3 trial|The Lancet Oncology|2022|50